Showing results (1-10 of 80) with videos related to
Sort By:
Pageof 8
Current Pharmaceutical Design|November 17, 2004
Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxideJennifer L Wilkinson-BerkaExpert Reviews in Molecular Medicine|September 25, 2004
Diabetes and retinal vascular disorders: role of the renin-angiotensin systemJennifer L Wilkinson-BerkaThe International Journal of Biochemistry & Cell Biology|September 17, 2005
Angiotensin and diabetic retinopathyJennifer L Wilkinson-BerkaJournal of Neuroinflammation|July 30, 2015
Inhibition of NOX1/4 with GKT137831: a potential novel treatment to attenuate neuroglial cell inflammation in the retinaDevy Deliyanti, Jennifer L Wilkinson-BerkaInvestigative Ophthalmology & Visual Science|February 25, 2005
The renin-angiotensin system and the developing retinal vasculatureStella Sarlos, Jennifer L Wilkinson-BerkaThescientificworldjournal|February 12, 2008
Update on the treatment of diabetic retinopathyJennifer L Wilkinson-Berka, Antonia G MillerCurrent Pharmaceutical Design|November 17, 2004
Angiotensin and bradykinin: targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathyJennifer L Wilkinson-Berka, Erica L FletcherCurrent Medicinal Chemistry|December 16, 2006
The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathyJennifer L Wilkinson-Berka, Christopher Wraight, George WertherPeptides|April 28, 2012
The retinal renin-angiotensin system: roles of angiotensin II and aldosteroneJennifer L Wilkinson-Berka, Alex Agrotis, Devy DeliyantiCurrent Clinical Pharmacology|November 24, 2012
The renin-angiotensin system and advanced glycation end-products in diabetic retinopathy: impacts and synergiesAntonia G Miller, Tong Zhu, Jennifer L Wilkinson-BerkaPageof 8